Comparison of cytotoxicities and anti-allergic effects of topical ocular dual-action anti-allergic agents [PDF]
BMC Ophthalmology, 2019 Background To investigate the cytotoxicities of the topical ocular dual-action anti-allergic agents (alcaftadine 0.25%, bepotastine besilate 1.5%, and olopatadine HCL 0.1%) on human corneal epithelial cells (HCECs) and their anti-allergic effects on ...
Sung Il Kim +5 more
doaj +5 more sources
Tic disorders and allergic diseases: mechanistic links and the impact of allergy management – a narrative review [PDF]
Frontiers in AllergyTic disorders are childhood-onset neuropsychiatric conditions that frequently co-occur with allergic diseases, including asthma, allergic rhinitis, and atopic dermatitis.
Lili Li +7 more
doaj +2 more sources
IgE, anti-IgE therapy, and regulatory T cells: new paradigms in allergic inflammation [PDF]
Frontiers in AllergyAllergic inflammation arises from a dysregulated immune response in which immunoglobulin E (IgE) plays a central pathogenic role. By binding to its high-affinity FcεRI on mast cells and basophils, IgE orchestrates the rapid activation and mediator ...
C. Benito-Villalvilla +6 more
doaj +2 more sources
Comparative Effects of Anti-Inflammatory Therapies on Olfactory Bulb Histopathology and Olfactory Function in a Rat Model of Experimental Allergic Rhinitis [PDF]
Journal of Inflammation ResearchEngin Kayıkçı,1 Hazal Kayıkçı2 1Ministry of Health, Etlik City Hospital, Department of Neurosurgery, Ankara, Turkiye; 2Division of Allergy and Clinical Immunology, Hacettepe University, Ankara ...
Kayıkçı E, Kayıkçı H
doaj +2 more sources
The High Affinity IgE Receptor (FcεRI) as a Target for Anti-allergic Agents
Allergology International, 2005 Prevention of the effector cell activation via high affinity IgE receptor (FcεRI) is thought to be a straightforward strategy for suppressing the allergic reaction.
Kyoko Takahashi, Chisei Ra
doaj +2 more sources
PLoS ONE, 2022 In vivo and in vitro anti-allergic activities of ethanol extract of Xenostegia tridentata (L.) D.F. Austin & Staples were investigated using passive cutaneous anaphylaxis reaction assay and RBL-2H3 cell degranulation assay, respectively.
Rinrada Suntivich +4 more
doaj +2 more sources
Self-assembling nanoparticles containing dexamethasone as a novel therapy in allergic airways inflammation. [PDF]
, 2013 Nanocarriers can deliver a wide variety of drugs, target them to sites of interest, and protect them from degradation and inactivation by the body. They have the capacity to improve drug action and decrease undesirable systemic effects.
Bratt, Jennifer M +6 more
core +12 more sources
Delivery options for sublingual immunotherapy for allergic rhinoconjunctivitis: clinical considerations for North America [PDF]
Rhinology Online, 2022 Background: Sublingual immunotherapy (SLIT) can be delivered via tablets (SLIT-T) or aqueous drops (SLIT-D). SLIT-D dosing recommendations using North American extracts were published in 2015.
Kent Lam +4 more
doaj +1 more source
Structures and Anti-Allergic Activities of Natural Products from Marine Organisms
Marine Drugs, 2023 In recent years, allergic diseases have occurred frequently, affecting more than 20% of the global population. The current first-line treatment of anti-allergic drugs mainly includes topical corticosteroids, as well as adjuvant treatment of antihistamine
Na Chen +8 more
doaj +1 more source
Streptochlorin suppresses allergic dermatitis and mast cell activation via regulation of Lyn/Fyn and Syk signaling pathways in cellular and mouse models. [PDF]
PLoS ONE, 2013 Allergic diseases are chronic inflammatory conditions with specific immune and inflammatory mechanisms. Scientific interest in understanding the mechanisms and discovering novel agents for the prevention and treatment of allergic disease is increasing ...
Seung-Hwan Lee +9 more
doaj +1 more source